Anyone using the genomic archetypes?

Hi

A couple of years ago, a group of archetypes dealing with results and interpretation of genomics/genetics analyses were made and published. You’ll find them here: Project: Genomics [openEHR Clinical Knowledge Manager]

The work group from back then are now picking their work up again, and some of the published ones will possibly be altered in the near future, and a couple of the yet not reviewed and published ones will be moved forward towards publishing.

The group would like to know:

  1. Has anyone used the actual archetypes in production yet? If so, the group is interested in feedback on their design.
  2. Are anyone interested in taking part in the future work, related to the genomic/genetic archetypes? Seeking especially domain experts to join.

Please respond below if you have experience from implementing the archetypes, or otherwise are interested in the work.

Regards,
Vebjørn Arntzen
CKA in international CKM, supporting the group

5 Likes

Hi Vebjorn,

I’m revising this topic as we are now using the genomic archetypes in a variety of ways in a project in Belfast, and I am aware of other projects starting to pop-up plus the session that @ce.mascia and @surfer presented at Ehrcon25.

The 2 areas we are covering are

  1. Pharmacogenetics, mostly using the PGX archetype Project: Team UK reviews [openEHR Clinical Knowledge Manager] but some use of the Genomic archetypes.
  2. Familial Cancer risk surveillance, based on the detection of germline variants during cancer investigation which makes extensive use of the standard Genomic variants.

It might be really helpful to do a show and tell of anyone in the space to ensure that we are aligning our templating as far as possible.

Who else is working in this area (including for cancer management)?

1 Like

@surfer , we did in HiGHmed too.

Is that the Molecular Biology template in Highmed CKM ? for Cancer markers?

Yes, but also the people from HiGHmed who were involved are part of the WG, afaik, that will pick them up again.

2 Likes